[1]	刘剑君, 赵雁林. 加大科技创新力度在结核病防治中积极推广适宜技术. 中国防痨杂志, 2019,41(6):587-590. doi: 10.3969/j.issn.1000-6621.2019.06.002.
[2]	贺文从, 赵雁林. 大力加强结核感染与发病机理及其实验室诊断技术的研究. 中国防痨杂志, 2018,40(10):1029-1033. doi: 10.3969/j.issn.1000-6621.2018.10.001.
[3]	Wilson DJ, CRyPTIC Consortium. GenomegaMap: Within-Species Genome-Wide dN/dS Estimation from over 10 000 Genomes. Mol Biol Evol, 2020 , 37(8):2450-2460. doi: 10.1093/molbev/msaa069. doi: 10.1093/molbev/msaa069 URL pmid: 32167543
[4]	CRyPTIC Consortium and the 100 000 Genomes Project, Caroline Allix-Béguec, Arandjelovic I, et al. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. N Engl J Med, 2018,379(15):1403-1415. doi: 10.1056/NEJMoa1800474. doi: 10.1056/NEJMoa1800474 URL pmid: 30280646
[5]	World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
[6]	宋红焕, 邵燕, 李燕, 等. 两种分子诊断技术对提高结核病病原学检测阳性率的评价研究. 结核病与肺部健康杂志, 2019,8(3):168-171. doi: 10.3969/j.issn.2095-3755.2019.03.004.

RichHTML

PDF (PC)